Wall Street Bulls to Roar Again in 2026: 3 Beaten-Down Stock Picks

U.S. equity benchmarks remain higher in 2026 (Dow +13%, S&P 500 +16.4%, Nasdaq +20.4%) supported by strong AI-driven demand and robust macro data: Q3 2025 GDP rose 4.3% with consumer spending up 3.5% YoY. Large banks and consultancies forecast massive AI infrastructure capex (Goldman/BoA >$1tn by 2028; JP Morgan/Citi $5tn cumulative by 2030; McKinsey ~$7tn by 2030), and four of the Magnificent 7 deployed $380bn of AI capex in 2025 (projected $440bn in 2026). Markets are also factoring in easing monetary policy (fed funds 3.50–3.75% with two 25bp cuts priced in for 2026) and stronger earnings (S&P 500 earnings +12.3% in 2026), while Zacks highlights three recovery candidates—MRVL (Celestial AI acquisition, strong data-center exposure), PCG (Diablo Canyon AI deployment, nuclear capacity tailwinds) and SNAP (Perplexity $400m deal)—as potential beneficiaries.

Analysis

Market structure: The AI-driven capex cycle crystallizes winners — hyperscalers, GPU/XPU leaders (NVDA), interconnect/photonic specialists (MRVL, AVGO) and data‑center REITs — while legacy, low‑performance incumbents face margin pressure as customers pay up for energy‑efficient scale solutions. Supply/demand favors sellers in the near term (heavy demand vs constrained fab/photonic capacity), supporting pricing power into 2026; however multi‑year capex guidance (consensus range $1T–$7T by 2030) implies large step‑ups in supply that can flip to oversupply by 2028 if buildout outpaces demand. Cross‑asset: two Fed cuts priced for 2026 should depress USD and push core rates down (benefiting long duration tech and T‑notes like TLT), raise commodity power/uranium sensitivity, and keep equity options vol elevated around NVDA/hyperscaler events.

Risk assessment: Tail risks include export controls/antitrust (GPU/IP restrictions), hyperscaler capex pullbacks, and operational integration failures (Celestial/MRVL, Perplexity/SNAP), plus specific utility regulatory or safety shocks for PCG. Immediate risks (days–weeks) center on earnings/guide misses and NVDA cadence; short term (3–6 months) centers on Fed action (April 2026 cut probability ~60%) and contract confirmations; long term (2026–2030) hinges on realization of multi‑trillion capex and concentration risk — a handful of hyperscalers drive >60% of demand, a single lost contract can halve growth assumptions for midcaps. Watch customer concentration (MRVL), revenue timing (SNAP/Perplexity payments starting 2026), and Diablo Canyon regulatory filings.

Key Decisions for Investors

• Establish a 2.5% portfolio long position in MRVL via a defined‑risk Jan 2027 call spread (buy 12‑18 month call ~30% OTM, sell higher strike ~70% OTM) to target asymmetric upside from Celestial integration and hyperscaler wins; set a hard stop if MRVL falls 20% from entry or if acquisition fails to close by Q1 FY2027.
• Add a 1.5% long in SNAP via 9–15 month LEAP calls or a bullish call spread to capture Perplexity revenue starting early 2026; exit if Perplexity payments are delayed beyond Q2 2026 or MAUs decline >5% sequentially.
• Construct a 1.5% pair trade: long MRVL (1.5%) vs short AVGO (1.5%) equal‑dollar to express idiosyncratic upside in photonics/SSD controllers versus Broadcom’s broad semiconductors moat; reduce pair if NVDA guidance shows slower AI demand growth or if AVGO reports unexpected margin expansion.
• Take a small 2% tactical long in 10‑year Treasuries (e.g., TLT) ahead of the Fed path (April 2026 cut odds ~60%); target a 20–60 bps drop in 10‑yr yields on confirmed cuts and unwind after the second cut or if CPI prints surprise upside (+0.3% month/month core).
• Deploy a conservative PCG trade: initiate a 1% long equity position financed by selling 6–9 month covered calls ~+10% OTM to harvest yield while retaining upside from nuclear/AI operations improvements; exit or hedge if California regulatory filings signal >$2bn incremental liability or plant operational issues arise.